EE171 Time to Diagnosis and Cost Effectiveness of Whole Exome Sequencing (WES) Position in the Diagnostic Pathways of Patients with Suspected Rare Genetic Disease

Autor: Degeling, K., Hayeems, R.Z., Tagimacruz, T., MacDonald, K.V., Seeger, T.A., Hartley, T., Boycott, K.M., Bernier, F.P., Mendoza-Londono, R., Marshall, D.
Zdroj: In Value in Health June 2023 26(6) Supplement:S90-S90
Databáze: ScienceDirect
Externí odkaz: